Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
Submitted by
admin
on September 15, 2016 - 9:50am
Source:
Marketwatch
News Tags:
Merck
Pfizer
diabetes
clinical trials
ertugliflozin
Headline:
Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
Do Not Allow Advertisers to Use My Personal information
